During the past decade, Dipartimento Oncologico - Ospedale S.Maria delle Croci conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 6 clinical trials were completed, i.e. on average, 26.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dipartimento Oncologico - Ospedale S.Maria delle Croci" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 14 trials, followed by "Hoffmann-La Roche" with 12 trials sponsored, "Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori" with 4 trials sponsored, "Fondazione Ricerca Traslazionale" with 3 trials sponsored and "Incyte Corporation" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dipartimento Oncologico - Ospedale S.Maria delle Croci" #1 collaborator was "Clinical Research Technology S.r.l." with 1 trials as a collaborator, "Clinical research technology Srl" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Jazz Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Dipartimento Oncologico - Ospedale S.Maria delle Croci" are "Carcinoma, Non-Small-Cell Lung" (5 trials), "Chronic Myeloid Leukemia" (3 trials), "Acute Lymphoblastic Leukemia" (2 trials), "BCR-ABL Positive" (2 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Dipartimento Oncologico - Ospedale S.Maria delle Croci" in a lesser frequency.

Most popular intervention types in "Dipartimento Oncologico - Ospedale S.Maria delle Croci" are "Drug" (32 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (4 trials), "Atezolizumab" (3 trials), "Docetaxel" (3 trials), "Gemcitabine" (3 trials) and "Pemetrexed" (3 trials). Other intervention names were less common.

The vast majority of trials in "Dipartimento Oncologico - Ospedale S.Maria delle Croci" are 33 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Dipartimento Oncologico - Ospedale S.Maria delle Croci". undefined are not yet recruiting, 2 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Dipartimento Oncologico - Ospedale S.Maria delle Croci, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Dipartimento Oncologico - Ospedale S.Maria delle Croci, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".